Granules India gains on European manufacturing approval for APIs, finished dosages

Granules India

30/01/2025 06:47

** Shares of Granules India  GRAN.NS  rise 3.6% to 565.2
rupees
    ** Pharma co said on Wednesday its Unit V facility received
European Union good manufacturing practice certificate for
active pharmaceutical ingredients (APIs) and finished dosages 
    ** Certification implies co has been assessed and deemed to
meet EU safety, health and environmental protection requirements
    ** Audit of the facility was done in Nov 2024, co says
    ** Stock gained 46% in 2024
     

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))